Unexpected benefits of intermittent hypoxia: Enhanced respiratory and nonrespiratory motor function

Physiology

Volumn 29, Issue 1, 2014, Pages 39-48

  Dale, E A ^a,b   Ben Mabrouk, F ^a   Mitchell, G S ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANOXIA; CYTOLOGY; HIPPOCAMPUS; HUMAN; METABOLISM; MOTONEURON; NERVE CELL PLASTICITY; PATHOPHYSIOLOGY; PHYSIOLOGY; RESPIRATORY FUNCTION; REVIEW; SLEEP DISORDERED BREATHING;

ANIMALS; ANOXIA; HIPPOCAMPUS; HUMANS; MOTOR NEURONS; NEURONAL PLASTICITY; RESPIRATORY PHYSIOLOGICAL PHENOMENA; SLEEP APNEA SYNDROMES;

EID: 84891497750     PISSN: 15489213     EISSN: 15489221     Source Type: Journal    
DOI: 10.1152/physiol.00012.2013     Document Type: Review

References (145)

1. Adamcio B, Sargin D, Stradomska A, Medrihan L, Gertler C, Theis F, Zhang M, Mueller M, Hassouna I, Hannke K, Sperling S, Radyushkin K, El-Kordi A, Schulze L, Ronnenberg A, Wolf F, Brose N, Rhee JS, Zhang W, Ehrenreich H. Erythropoietin enhances hippocampal long-term potentiation and memory. BMC Biol 6: 37, 2008.
2. Atwal JK, Massie B, Miller FD, Kaplan DR. The TrkN-Shc site signals neuronal surivival and local axon growth via MEK and PI3-Kinase. Neuron 27: 265-277, 2000.
3. Bach KB, Mitchell GS. Hypoxia-induced facilitation of respiratory activity is serotonin dependent. Respir Physiol 104: 251-260, 1996.
4. Baker-Herman TL, Fuller DD, Bavis RW, Zabka AG, Golder FJ, Doperalski NJ, Johnson RA, Wat-ters JJ, Mitchell GS. BDNF is necessary and sufficient for spinal respiratory plasticity following intermittent hypoxia. Nat Neurosci 7: 48-55, 2004.
5. Baker-Herman TL, Mitchell GS. Phrenic long-term facilitation requires spinal serotonin receptor activation and protein synthesis. J Neurosci 22: 6239-6246, 2002.
6. Barde YA, Edgar D, Thoenen H. Purification of a new neurotrophic factor from mammalian brain. EMBO J 1: 549-553, 1982.
7. Baumgartner BJ, Shine HD. Targeted transduc-tion of CNS neurons with adenoviral vectors carrying neurotrophic factor genes confers neuroprotection that exceeds the transduced population. J Neurosci 17: 6504-6511, 1997.
8. Berger S, Lavie L. Endothelial progenitor cells in cardiovascular disease and hypoxia-potential implications to obstructive sleep apnea. Transl Res 158: 1-13, 2011.
9. Berry RB, Budhiraja R, Gottlieb DJ, Gozal D, Iber C, Kapur VK, Marcus CL, Mehra R, Parthasarathy S, Quan SF, Redline S, Strohl KP, Davidson Ward SL, Tangredi MM. Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 8: 597-619, 2012.
10. Bert P. La Pression Barométrique: Recherches de Physiologie Expérimentale. Paris: Masson, 1878.
11. Bert P. Sur la richesse en hemoglobine du sang des animaux vivant sur les hauts lieux. CR Acad Sci Paris 94: 805-807, 1882.
12. Bernaudin M, Marti HH, Roussel S, Divoux D, Nouvelot A, MacKenzie ET, Petit E. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 19: 643-651, 1999.
13. Bliss TVP, Collingridge G. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361: 31-39, 1993.
14. Bradley DM, Beaman FD, Moore DB, Kidd K, Heaton MB. Neurotrophic factors BDNF and GDNF protect embryonic chick spinal cord mo-toneurons from ethanol neurotoxicity in vivo. Brain Res Dev Brain Res 112: 99-106, 1999.
15. Bramham CR, Messaoudi E. BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog Neurobiol 76: 99-125, 2005.
16. Breitburg DL. Effects of hypoxia, and the balance between hypoxia and enrichment, on coastal fishes and fisheries. Estuaries 25: 767-781, 2002.
17. Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanoerolle NC, Cerami C, Itri LM, Cerami A. Erythropoietin crosses the bloodbrain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 97: 10526-10531, 2000.
18. Bucks RS, Olaithe M, Eastwood P. Neurocogni-tive function in obstructive sleep apnea: a meta-review. Respirology 18: 61-70, 2013.
19. Cai Z, Manalo DJ, Wei G, Rodriguez ER, Fox-Talbot K, Lu H, Zweier JL, Semenza GL. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 108: 79-85, 2003.
20. Cao L, Jiao X, Zuzga DS, Liu Y, Fong DM, Young D, During MJ. VEGF links hippocampal activity with neurogenesis, learning and memory. Nat Genet 36: 827-835, 2004.
21. Chapman LJ, MacKenzie DJ. Behavioral responses and ecological consequencesHypoxia, edited by Richards JG, Farrell AP, Brauner CJ. San Diego, CA: Academic, 2009 25-77.
22. Chapman RF, Stray-Gundersen J, Levine BD. Individual variation in response to altitude training. J Appl Physiol 85: 1448-1456, 1998.
23. Celik M, Gökmen N, Erbayraktar S, Akhisaroglu M, Konakc S, Ulukus C, Genc S, Genc K, Sagiro-glu E, Cerami A, Brines M. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc Natl Acad Sci USA 99: 2258-2263, 2002.
24. Chen J, Dinger B, Jyung R, Stensaas L, Fidone S. Altered expression of vascular endothelial growth factor and FLK-1 receptor in chronically hypoxic rat carotid body. Adv Exp Med Biol 536: 583-591, 2003.
25. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM, Feder J. Tumor vascular permeability factor stimulates endothelial cell growth and angiogen-esis. J Clin Invest 84: 1470-1478, 1989.
26. Dale EA, Mitchell GS. Spinal vascular endothelial growth factor (VEGF) and erythropoietin (EPO) induced phrenic motor facilitation after repetitive acute intermittent hypoxia. Respir Physiol Neurobiol 185: 481-488, 2013.
27. Dale EA, Satriotomo I, Mitchell GS. Cervical spinal erythropoietin induces phrenic motor facilitation via extracellular signal-regulated protein kinase and Akt signaling. J Neurosci 32: 5973- 5983, 2012.
28. Dale-Nagle EA, Hoffman MS, MacFarlane PM, Mitchell GS. Multiple pathways to long-lasting phrenic motor facilitation. Adv Exp Med Biol 669: 225-230, 2010.
29. Dale-Nagle EA, Hoffman MS, MacFarlane PM, Satriotomo I, Lovett-Barr MR, Vinit S, Mitchell GS. Spinal plasticity following intermittent hyp-oxia: implications for spinal injury. Ann NY Acad Sci 1198: 252-259, 2010.
30. Dale-Nagle EA, Satriotomo I, Mitchell GS. Spinal vascular endothelial growth factor induces phrenic motor facilitation via extracellular signal-regulated kinase and Akt signaling. J Neurosci 31: 7682-7690, 2011.
31. Devinney MJ, Huxtable AG, Nichols NL, Mitchell GS. Hypoxia-induced phrenic long-term facilitation: emergent properties. Ann NY Acad Sci 1279: 143-153, 2013.
32. Digicaylioglu M, Bichet S, Marti HH, Wenger RH, Rivas LA, Bauer C, Gassmann M. Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc Natl Acad Sci USA 92: 3717-3720, 1995.
33. Fabel K, Fabel K, Tam B, Kaufer D, Baiker A, Simmons N, Kuo CJ, Palmer TD. VEGF is necessary for exercise-induced adult hippocampal neu-rogenesis. Eur J Neurosci 18: 2803-2812, 2003.
34. Fava C, Montagnana M, Favaloro EJ, Guidi GC, Lippi G. Obstructive sleep apnea syndrome and cardiovascular diseases. Semin Thromb Hemost 37: 280-297, 2011.
35. Fletcher EX, Lesske J, Qian W, Miller CC 3rd, Unger T. Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats. Hypertension 19: 555-561, 1992.
36. Franke TF, Kaplan DR, Cantley LC. PI3K: downstream AKTion blocks apoptosis. Cell 88: 435- 437, 1997.
37. Fregosi RF, Mitchell GS. Long-term facilitation of inspiratory intercostal nerve activity following carotid sinus nerve stimulation in cats. J Physiol 477: 469-479, 1994.
38. Fuller DD, Johnson SM, Olsen EB Jr, Mitchell GS. Synaptic pathways to phrenic motoneurons are enhanced by chronic intermittent hypoxia after cervical spinal injury. J Neurosci 23: 2993-3000, 2003.
39. Girgenti MJ, Hunsberger J, Duman CH, Sathya-nesan M, Terwillinger R, Newton SS. Erythropoi-etin induction by electroconvulsive seizure, gene regulation, and antidepressant-like behavioral effects. Biol Psychiatry 66: 267-274, 2009.
40. Golan MH, Mane R, Molczadzki G, Zuckerman M, Kaplan-Louson V, Huleihel M, Perez-Polo JR. Impaired migration signaling in the hippocampus following prenatal hypoxia. Neuropharmacology 57: 511-522, 2009.
41. Golder FJ, Ranganathan L, Satriotomo I, Hoffman M, Lovett-Barr MR, Watters JJ, Baker-Herman TL, Mitchell GS. Spinal adenosine A2a receptor activation elicits long-lasting phrenic motor facilitation. J Neurosci 28: 2033-2042, 2008.
42. Gora-Kupilas K, Josko J. The neuroprotective function of vascular endothelial growth factor (VEGF). Folia Neuropathol 43: 31-39, 2005.
43. Gozal D, Hakim F, Kheirandish-Gozal L. Chemo-receptors, baroreceptors, and autonomic deregulation in children with obstructive sleep apnea. Respir Physiol Neurobiol 185: 177-185, 2013.
44. Gozal D, Daniel JM, Dohanich GP. Behavioral and anatomical correlates for chronic episodic hyp-oxia during sleep in the rat. J Neurosci 21: 2442- 2450, 2001.
45. Graeber MB. Changing face of microglia. Science 330: 783-788, 2010.
46. Graham JB. Air Breathing Fishes: Evolution, Diversity, and Adaptation. San Diego, CA: Academic, 1997.
47. Grogg-Damberger M, Ralls F. Cognitive dysfunction and obstructive sleep apnea: from cradle to tomb. Curr Opin Pulm Med 18: 580-587, 2012.
48. Gu H, Lin M, Liu J,. Selective impairment of central mediation of baroreflex in anesthetized young adult Fischer 344 rats after chronic intermittent hypoxia. Am J Physiol Heart Circ Physiol 293: H2809-H2818, 2007.
49. Hayashi T, Sakurai M, Abe K, Sadahiro M, Tabayashi K, Itoyama Y. Expression of angio-genic factors in rabbit spinal cord after transient ischaemia. Neuropathol Appl Neurobiol 25: 63- 71, 1999.
50. Hayes HB, Chavtal S, Ting LH, Rymer WZ, Mitchell GS, Trumbower RD. Effect of single-day acute intermittent hypoxia on overground walking speed and muscle coordination in persons with incomplete spinal cord injury. Soc Neurosci Abstract: 252.17/M16, 2012.
51. Hetman M, Kanning K, Cavanaugh JE, Xia Z. Neuroprotection by brain derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phsophatidylinositol 3-kinase. J Biol Chem 274: 22569-22580, 1999.
52. Hoffman MS, Mitchell GS. Spinal 5-HT7 receptor activation induces long-lasting phrenic motor facilitation. J Physiol 589: 1397-1407, 2011.
53. Hoffman MS, Nichols NL, Macfarlane PM, Mitchell GS. Phrenic long-term facilitation after acute intermittent hypoxia requires spinal ERK activation but not TrkB synthesis. J Appl Physiol 113: 1184-1193, 2012.
54. Hubold C, Lang UE, Gehring H, Schultes B, Schweiger U, Peters A, Hellweg R, Oltmanns KM. Increased serum brain-derived neurotrophic factor protein upon hypoxia in healthy young men. J Neural Transm 116: 1221-1225, 2009.
55. Huxtable AG, Vinit S, Windelborn JA, Crader SM, Guenther CH, Watters JJ, Mitchell GS. Systemic inflammation impairs respiratory chemoreflexes and plasticity. Respir Physiol Neurobiol 178: 482- 489, 2011.
56. Huxtable AG, Smith SM, Vinit S, Watters JJ, Mitchell GS. Systemic LPS induces spinal inflammatory gene expression and impairs phrenic long-term facilitation following acute intermittent hypoxia. J Appl Physiol 114: 879-887, 2013.
57. Iwasaki Y, Ikeda K, Ichikawa Y, Igarashi O, Iwamoto K, Kinoshita M. Protective effect of in-terleukin-3 and erythropoietin on motor neuron death after neonatal axotomy. Neurol Res 24: 643-646, 2002.
58. Jiang X, Zhu D, Okagaki P, Lipsky R, Wu X, Ba-naudha K, Mearow K, Strauss KI, Marini AM. N-methyl-D-aspartate and TrkB receptor activation in cerebellar granule cells: an in vitro model of preconditioning to stimulate intrinsic survival pathways in neurons. Ann NY Acad Sci 993: 134- 145, 2003.
59. Jones JRE. The reactions of fish to water of low oxygen concentration. J Exp Biol 29: 403-415, 1952.
60. Jourdanet D. Influence de la Pression de L'air sur la Vie de L'homme. Paris: Masson, 1875.
61. Kilic E, Kilic U, Soliz J, Bassetti CL, Gassmann M, Hermann DM. Brain derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways. FASEB J 19: 2026-2028, 2005.
62. Kline DD, Ramirez-Navarro A, Kunze DL. Adaptive depression in synaptic transmission in the nucleus of the solitary tract after in vivo chronic intermittent hypoxia: evidence for homeostatic plasticity. J Neuroscience 27: 4663-4673, 2007.
63. Koistinen PO, Rusko H, Irjala Rajamaki A K, Pent-tinen K, Sarparanta VP, Karpakka J, Leppaluoto J. EPO, red cells, and serum tranferrin receptor in continuous and intermittent hypoxia. Med Sci Sports Exerc 32: 800-804, 2000.
64. Kramer DL. Dissolved oxygen and fish behaviour. Environ Biol Fishes 18: 81-92, 1987.
65. Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19: 312-318, 1996.
66. Lee E, Son H. Adult hippocampal neurogenesis and related neurotrophic factors. BMB Rep 42: 239-244, 2009.
67. Lindvall O, Ernfors P, Bengzon J, Kokaia Z, Smith ML, Siesjoe BK, Persson H. Differential regulation of mRNAs for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the adult rat brain following cerebral ischemia and hypoglycemic coma. Proc Natl Acad Sci USA 89: 648-652, 1992.
68. Ling L, Fuller DD, Bach KB, Kinkead R, Olson EB Jr, Mitchell GS. Chronic intermittent hypoxia elicits serotonin-dependent plasticity in the central neural control of breathing. J Neurosci 21: 5381-5388, 2001.
69. Lu B, Gottschalk W. Modulation of hippocampal synaptic transmission and plasticity by neurotro-phins. Prog Brain Res 128: 231-241, 2000.
70. Lu Y, Christian K, Lu B. BDNF: a key regulator for protein synthesis dependent LTP and long-term memory? Neurobiol Learn Mem 89: 312-323, 2008.
71. Lurie A. Endothelial dysfunction in adults with obstructive sleep apnea. Adv Cardiol 46: 139- 170, 2011.
72. Lurie A. Inflammation, oxidative stress, and pro-coagulant and thrombotic activity in adults with obstructive sleep apnea. Adv Cardiol 46: 43-66, 2011.
73. Lovett-Barr MR, Satriotomo I, Muir G, Wilker-son JER, Hoffman MS, Vinit S, Mitchell GS. Repetitive intermittent hypoxia induces respiratory and somatic motor recovery following chronic cervical spinal injury. J Neurosci 32: 3591-3600, 2012.
74. MacFarlane PM, Mitchell GS. Episodic spinal serotonin receptor activation elicits long-lasting phrenic motor facilitation by an NADPH oxidase-dependent mechanism. J Physiol 587: 5469-5481, 2009.
75. Mahamed S, Mitchell GS. Is there a link between intermittent hypoxia-induced respiratory plasticity and obstructive sleep apnoea? Exp Physiol 92: 27-37, 2007.
76. Mahamed S, Mitchell GS. Respiratory long-term facilitation: too much or too little of a good thing? Adv Exp Med Biol 605: 224-227, 2008.
77. Malenka RC, Nicoll RA. Long-term potentiation-a decade of progress? Science 285: 1870-1874, 1999.
78. Mantilla CB, Zhan WZ, Sieck GC. Neurotrophins improve neuromuscular transmission in the adult rat diaphragm. Muscle Nerve 29: 381-386, 2004.
79. Marini AM, Rabin SJ, Lipsky RH, Mocchetti. Activity dependent release of brain-derived neu-rotrophic factor underlies the neuroprotective effect of N-methyl-D-aspartate. J Biol Chem 273: 29394-29399, 1998.
80. Marini AM, Jiang X, Wu X, Tian F, Zhu D, Okagaki P, Lipsky RH. Role of brain-derived neurotrophic factor and NF-kappaB in neuronal plasticity and survival: from genes to phenotype. Resto Neurol Neurosci 222: 121-130, 2004.
81. Martens LK, Kirschner KM, Warnecke C, Scholz H. Hypoxia-inducible factor-1 (HIF-1) is a tran-scriptional activator of the TrkB neurotrophin receptor gene. J Biol Chem 282: 14379-14388, 2007.
82. Marti HH, Wenger RH, Rivas LA, Straumann U, Digicaylioglu M, Henn V, Yonekawa Y, Bauer C, Gassmann M. Erythropoietin gene expression in human, monkey and murine brain. Eur J Neurosci 8: 666-676, 1996.
83. Masuda S, Okano M, Yamagishi K, Nagao M, Ueda M, Sasaki R. A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes. J Biol Chem 269: 19488-19493, 1994.
84. Mateika JH, Narwani G. Intermittent hypoxia and respiratory plasticity in humans and other animals: does exposure to intermittent hypoxia promote or mitigate sleep apnoea? Exp Physiol 94: 279-296, 2009.
85. McKay LC, Janczewski WA, Feldman JL. Episodic hypoxia evokes long-term facilitation of genio-glossus muscle activity in neonatal rats. J Physiol 557: 13-18, 2004.
86. Mennini T, De Paola M, Bigini P, Mastrotto C, Fumagalli E, Barbera S, Mengozzi M, Viviani B, Corsini E, Marinovich M, Torup L, Van Beek J, Leist M, Brines M, Cerami A, Ghezzi P. Nonhe-matopoietic erythropoietin derivatives prevent motoneuron degeneration in vitro and in vivo. Mol Med 7-8: 153-160, 2006.
87. Miskowiak KW, Vinberg M, Harmer CJ, Ehren-reich H, Kessing LV. Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression. Psychopharmacology (Berl) 219: 687-698, 2012.
88. Mitchell GS. Respiratory plasticity following intermittent hypoxia: a guide for novel therapeutic approaches to ventilatory control disorders. In: Genetic Basis for Respiratory Control Disorders, edited by Gaultier C. New York: Springer, 2007.
89. Mitchell GS, Baker TL, Nanda SA, Fuller DD, Zabka AG, Hodgeman BA, Bavis RW, Mack KJ, Olsen EB Jr. Invited review: Intermittent hypoxia and respiratory plasticity. J Appl Physiol 90: 2466-2475, 2001.
90. Mitchell GS, Johnson SM. Neuroplasticity in respiratory motor control. J Appl Physiol 94: 358-374, 2003.
91. Mitchell GS, Terada J. Should we standardize protocols and preparations used to study respiratory plasticity? Respir Physiol Neurobiol 177: 93-97, 2011
92. Nagańska E, Taraszewska A, Matyja E, Grieb P, Rafałowska J. Neuroprotective effect of erythro-poietin in amyotrophic lateral sclerosis (ALS) model in vitro. Ultrastructural Study Folia Neuro-pathol 48: 35-44, 2010.
93. Nanduri J, Makarenko V, Reddy VD, Yuan G, Pawar A, Wang N, Khan SA, Zhang X, Kinsman B, Peng YJ, Kumar GK, Fox AP, Godley LA, Se-menza GL, Prabhakar NR. Epigenetic regulation of hypoxic sensing disrupts cardiorespiratory ho-meostasis. Proc Natl Acad Sci USA 109: 2515- 2520, 2012.
94. Narumiya S, Ohno M, Tanaka N, Yamano T, Shi-mada M. Enhanced expression of full-length TrkB receptors in young rat brain with hypoxic/isch-emic injury. Brain Res 797: 278-286, 1998.
95. Nichols NL, Gowing G, Satriotomo I, Nashold LJ, Dale EA, Suzuki M, Avalos P, Mulcrone PL, McHugh J, Svendsen CN, Mitchell GS. Intermittent hypoxia and stem cell implants preserve breathing capacity in a rodent model of ALS. Am J Respir Crit Care Med 187: 535-542, 2012.
96. Niu C, Yip HK. Neuroprotective signaling mechanisms of telomerase are regulated by brain-derived neurotrophic factor in rat spinal cord motor neurons. J Neuropathol Exp Neurol 70: 634- 652, 2011.
97. Pati S, Orsi SA, Moore AN, Dash PK. Intra-hip-pocampal administration of the VEGF receptor blocker PTK787/ZK222584 impairs long-term memory. Brain Res 1256: 85-91, 2009.
98. Pihl L, Baden SP, Diaz RJ. Effects of periodic hypoxia on distribution of demersal fish and crustaceans. Mar Biol 108: 349-360, 1991.
99. Powell FL, Milsom WK, Mitchell GS. Time domains of the hypoxic ventilatory response. Respir Physiol 112: 123-134, 1998.
100. Ramar K, Caples SM. Vascular changes, cardiovascular disease and obstructive sleep apnea. Future Cardiol 7: 241-249, 2011.
101. Reeves SR, Mitchell GS, Gozal (2006) D. Early postnatal chronic intermittent hypoxia modifies hypoxic respiratory responses and long-term phrenic facilitation in adult rats. Am J Physiol Regul Integr Comp Physiol 290: R1664-R1671, 2006.
102. Reichardt LF. Neurotrophin-regulated signaling pathways. Philos Trans R Soc Lond B Biol Sci 361: 1545-1564, 2006.
103. Reid SG, Sunin L, Milsom WK. The cardiorespira-tory system in tropical fishes: structure, function, and control. Fish Physiol 21: 225-274, 2006.
104. Robinson CJ, Stringer SE. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J Cell Sci 114: 853-865, 2001.
105. Row BW. Intermittent hypoxia and cognitive function: implications from chronic animal models. Adv Exp Med Biol 618: 51-67, 2007.
106. Sargin D, El-Kordi A, Agarwal A, Muller M, Wojcik SM, Hassouna I, Sperking S, Nave KA, Ehrenreich H. Expression of constitutively active erythropoi-etin receptor in pyramidal neurons of cortex and hippocampus boosts higher cognitive functions in mice. BMC Biol 9: 27, 2011.
107. Satriotomo I, Dale EA, Dahlberg JM, Mitchell GS. Repetitive acute intermittent hypoxia increases expression of proteins associated with plasticity in the phrenic motor nucleus. Exp Neurol 237: 103-115, 2012.
108. Schinder AF, Poo M. The neurotrophin hypothesis for synaptic plasticity. Trends Neurosci 23: 639-645, 2000.
109. Xie H, Leung KL, Chen L, Chan YS, Ng PC, Fok TF, Wing YK, Li AM, Yung WH. Brain-derived neurotrophic factor rescues and prevents chronic intermittent hypoxia-induced impairment of hip-pocampal long-term synaptic plasticity. Neuro-biol Dis 40: 155-162, 2010.
110. Schurmann H, Claireaux G, Chartois H. Changes in vertical distribution of sea bass (Dicentrarchus labrax L) during a hypoxic episode. Hydrobiol 371/372: 207-213, 1998.
111. Semenza GL. Hypoxia-inducible factor 1 (HIF-1) pathway. Sci STKE 2007: cm8, 2007.
112. Senger DR, Perruzzi CA, Feder J, Dvorak HF. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 46: 5629-5632, 1986.
113. Serebrovskaya TV. Intermittent hypoxia research in the former soviet union and the commonwealth of the independent states: history and review of the concept and selected applications. High Alt Med Biol 3: 205-221, 2002.
114. Shao G, Zhang R, Wang ZL, Gao CY, Huo X, Lu (2006-2007) GW. Hypoxic preconditiong improves spatial cognitive ability in mic. Neurosig-nals 15: 314-321, 2006-2007.
115. Shen J, Wu Y, Xu JY, Zhang J, Sinclair SH, Yanoff M, Xu G, Li W, Xu GT. ERK-and Akt-dependent neuroprotection by erythropoietin (EPO) against glyoxal-AGEs via modulation of Bcl-xL, Bax, and BAD. Invest Ophthalmol Vis Sci 51: 35-46, 2010.
116. Sieck GC, Mantilla CB. Role of neurotrophins in recovery of phrenic motor function following spinal cord injury. Respir Physiol Neurobiol 169: 218-225, 2009.
117. Sirén AL, Knerlich F, Poser W, Gleiter CH, Bruck W, Ehrenreich H. Erythropoietin and erythropoi-etin receptor in human ischemic/hypoxic brain. Acta Neuropathol (Berl) 101: 271-276, 2001.
118. Soliz J, Joseph V, Soulage C, Becskei C, Vogel J, Pequignot JM, Ogunshola O, Gassmann M. Erythropoietin regulates hypoxic ventilation in mice by interacting with brainstem and carotid bodies. J Physiol 568: 559-571, 2005.
119. Soliz J, Soulage C, Hermann DM, Gassmann M. Acute and chronic exposure to hypoxia alters ventilatory pattern but not minute ventilation of mice overexpressing erythropoietin. Am J Physiol Regul Integr Comp Physiol 293: R1702-R1710, 2007.
120. Soliz J, Gassmann M, Joseph V. Downregulation of soluble erythropoietin receptor in the mouse brain is required for the ventilatory acclimatization to hypoxia. J Physiol 583: 329-336, 2007.
121. Spedding M, Gressens P. Neurotrophins and cy-tokines in neuronal plasticity. Novartis Found Symp 289: 222-233; discussion 233-240, 2008.
122. Storkebaum E, Lambrechts D, Carmeliet P. VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioes-says 26: 943-954, 2004.
123. Tabakman R, Lecht S, Sephanova S, Arien-Zakay H, Lazarovici P. Interactions between the cells of the immune and nervouse system: neurotrophins as neuroprotection mediators in CNS injury. Prog Brain Res 146: 387-401, 2004.
124. Tasali E, Ip MS. Obstructive sleep apnea and metabolic syndrome: alterations in glucose metabolism and inflammation. Proc Am Thoracic Soc 5: 207-217, 2008.
125. Terada J, Mitchell GS. Diaphragm long-term facilitation following acute intermittent hypoxia during wakefulness and sleep. J Appl Physiol 110: 1299-310, 2011.
126. Trumbower RD, Jayaraman A, Mitchell GS, Rymer WZ. Exposure to acute intermittent hyp-oxia augments somatic motor function in humans with incomplete spinal cord injury. Neurorehabil Neural Repair 26: 163-172, 2012.
127. Vinit S, Lovett-Barr MR, Mitchell GS. Intermittent hypoxia induces functional recovery following cervical spinal injury. Respir Physiol Neurobiol 169: 210-217, 2009.
128. Vogt M, Hoppeler H. Is hypoxia training good for muscles and exercise performance? Prog Cardio-vasc Dis 52: 525-533, 2010.
129. Walton M, Connor B, Lawlor P, Young D, Siri-manne E, Gluckman P, Cole G, Dragunow M. Neuronal death and survival in two models of hypoxic ischemic brain damage. Brain Res Brain Res Rev 29: 137-168, 1999.
130. Wang H, Ward N, Boswell M, Katz DM. Secretion of brain-derived neurotrophic factor from brain microvascular endothelial cells. Eur J Neurosci 23: 1665-1670, 2006.
131. Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic helix-loop-helix PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 92: 5510-5514, 1995.
132. Wang GL, Semenza GL. Purification and characterization of hypoxia inducible factor 1. J Biol Chem 270: 1230-1237, 1995.
133. Weber A, Maier RF, Hoffmann U, Grips M, Hop-penz M, Aktas AG, Heinemann U, Obladen M, Schuchmann S. Erythropoietin improves synaptic transmission during and following ischemia in rat hippocampal slice cultures. Brain Res 958: 305-311, 2002.
134. Wilber RL, Stray-Gundersen J, Levine BD. Effect of hypoxic "dose" on physiological responses and sea level performance. Med Sci Sports Exerc 39: 1590-1599, 2007.
135. Wilkerson JER, Mitchell GS. Daily intermittent hypoxia augments spinal BDNF levels, ERK phos-phorylation, and respiratory long-term facilitation. Exp Neurol 217: 116-123, 2009.
136. Xiong Y, Mahmood A, Meng Y, Zhang Y, Qu C, Schallert T, Chopp M. Delayed administration of erythropoietin reducing hippocampal cell loss, enhancing angiogenesis and neurogenesis, and improving functional outcome following traumatic brain injury in rats: comparison of treatment with single and triple dose. J Neurosurg 113: 598-608, 2010.
137. Yeo EJ, Cho YS, Kim MS, Park JW. Contribution of HIF-1a or HIF2a to erythropoietin expression: in vivo evidence based on chromatin immunopre-cipitation. Ann Hematoi 87: 11-17, 2008.
138. Yuan G, Nanduri J, Khan S, Semenza GL, Prab-hakar NR. Induction of HIF-1a expression by intermittent hypoxia: involvement of NADPH oxidase, Ca2 signaling, prolyl hydroxylases and mTOR. J Ceii Physioi 217: 674-685, 2008.
139. Yuan G, Nanduri J, Bhasker CR, Semenza GL, Prabhakar NR. Ca2+/calmodulin kinase-depen-dent activation of hypoxia inducible factor 1 tran-scriptional activity in cells subjected to intermittent hypoxia. J Bioi Chem 280: 4321-4328, 2005.
140. Zabka AG, Behan M, Mitchell GS. Long term facilitation of respiratory motor output decreases with age in male rats. J Physioi 531: 509-514, 2001.
141. Zachary I. Neuroprotective role of vascular endo-thelial growth factor: signaling mechanisms, biological function, and therapeutic potential. Neurosignais 14: 207-221, 2005.
142. Zhan WZ, Mantilla CB, Sieck GC. Regulation of neuromuscular transmission by neurotrophins. Sheng Li Xue Bao 55: 617-624, 2003.
143. Zhang JX, Chen XQ, Du JZ, Chen QM, Zhu CY. Neonatal exposure to intermittent hypoxia enhances mice performance in water maze and 8-arm radial maze tasks. J Neurobioi 65: 72-84, 2005.
144. Zhang F, Signore AP, Zhou Z, Wang S, Cao G, Chen (2006) J. Erythropoietin protects CA1 neurons against global cerebral ischemia in rat: potential signaling mechanisms. J Neurosci Res 83: 1241-1251, 2006.
145. Zhu XH, Yan HC, Zhang J, Qu HD, Qiu XS, Chen L, Lis SJ, Cao X, Bean JC, Chen LH, Qin XH, Liu JH, Bai XC, Mei L, Gao TM. Intermittent hypoxia promotes hippocampal neurogenesis and produces antidepressant-like effects in adult rats. J Neurosci 30: 12653-12663, 2010.